These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21053131)

  • 1. Toxicity methods for CPPs.
    Lundin P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():195-205. PubMed ID: 21053131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity, Immunogenicity, Uptake, and Kinetics Methods for CPPs.
    Uusna J; Langel K; Langel Ü
    Methods Mol Biol; 2015; 1324():133-48. PubMed ID: 26202267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of proteoglycan involvement in CPP-mediated delivery.
    Wittrup A; Zhang SH; Belting M
    Methods Mol Biol; 2011; 683():99-115. PubMed ID: 21053125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium and membrane repair.
    Palm-Apergi C; Hällbrink M
    Methods Mol Biol; 2011; 683():157-64. PubMed ID: 21053128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.
    Puttonen KA; Lehtonen S; Lampela P; Männistö PT; Raasmaja A
    Toxicol In Vitro; 2008 Feb; 22(1):182-9. PubMed ID: 17764891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides.
    Rydberg HA; Matson M; Amand HL; Esbjörner EK; Nordén B
    Biochemistry; 2012 Jul; 51(27):5531-9. PubMed ID: 22712882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptides: a comparative membrane toxicity study.
    Saar K; Lindgren M; Hansen M; Eiríksdóttir E; Jiang Y; Rosenthal-Aizman K; Sassian M; Langel U
    Anal Biochem; 2005 Oct; 345(1):55-65. PubMed ID: 16137634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of nucleoside phosphates into live cells by complex formation with different CPPs and JBS-nucleoducin.
    Mussbach F; Pietrucha R; Schaefer B; Reissmann S
    Methods Mol Biol; 2011; 683():375-89. PubMed ID: 21053144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative cytotoxicity assessment based on various cellular damages.
    Kim H; Yoon SC; Lee TY; Jeong D
    Toxicol Lett; 2009 Jan; 184(1):13-7. PubMed ID: 18992794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
    Kamide K; Nakakubo H; Uno S; Fukamizu A
    Int J Mol Med; 2010 Jan; 25(1):41-51. PubMed ID: 19956900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
    Kilk K; Mahlapuu R; Soomets U; Langel U
    Toxicology; 2009 Nov; 265(3):87-95. PubMed ID: 19799958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of cell penetrating peptides (CPPs).
    Kerkis A; Hayashi MA; Yamane T; Kerkis I
    IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transduction of cell-penetrating peptides into induced pluripotent stem cells.
    Yukawa H; Noguchi H; Nakase I; Miyamoto Y; Oishi K; Hamajima N; Futaki S; Hayashi S
    Cell Transplant; 2010; 19(6):901-9. PubMed ID: 20587149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.